Skip to main content

Table 1 Outcome measures and assessments

From: The synchronized trial on expectant mothers with depressive symptoms by omega-3 PUFAs (SYNCHRO): Study protocol for a randomized controlled trial

 

Baseline

12 weeks

1 month after childbirth

Primary outcome

   

HAMD

+

+

+

Secondary outcome

   

MINI

+

+

+

EPDS

+

+

+

BDI-II

+

+

+

Plasma

+

+

+

Serum

+

+

+

Other measures

   

Demographics

+

  

Obstetric outcomes

  

+

Erythrocyte

+

+

+

Adverse effects

 

+

+

  1. HAMD hamilton rating scale for depression (HAMD), MINI mini international neuropsychiatric interview, EPDS Edinburgh postnatal depression scale, BDI-II beck depression inventory-II